Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Disease entities : Centogene n.v. save search
CENTOGENE and the Laboratory of Human Genetics of Infectious Diseases at Institut Imagine Announce Rare Disease Research Collaboration
Published: 2024-01-25 (Crawled : 12:00) - globenewswire.com
CNTG | $0.463 0.43% 0.43% 79K
|
Commercial Services
|
| O: -2.5%
H: 5.13%
C: 0.0%
rare disease research collaboration
CENTOGENE and The Michael J. Fox Foundation Announce Research Project to Validate Genetic Risk Factors of Parkinson’s Disease Using Multiomics
Published: 2024-01-23 (Crawled : 12:00) - globenewswire.com
CNTG | $0.463 0.43% 0.43% 79K
|
Commercial Services
|
| O: 0.0%
H: 0.0%
C: 0.0%
disease genetic risk research parkinson’s
CENTOGENE, University College London, and Global Team of Researchers Discover Gene Associated With New Neurodevelopmental Disease Linked to Early-Onset Dystonia and Parkinsonism
Published: 2023-11-14 (Crawled : 13:30) - globenewswire.com
CNTG | $0.463 0.43% 0.43% 79K
|
Commercial Services
|
| O: 10.25%
H: 0.78%
C: -0.78%
disease global
CENTOGENE Announces Publication Establishing Lyso-Gb1 as a Predictive Biomarker for Gaucher Disease Patients
Published: 2023-09-01 (Crawled : 12:00) - globenewswire.com
CNTG | $0.463 0.43% 0.43% 79K
|
Commercial Services
|
| O: 0.84%
H: 0.0%
C: -5.83%
disease biomarker publication
CENTOGENE Biodatabank Reveals Unique Genetic Variants in World's Largest Niemann-Pick Type C1 Disease Cohort
Published: 2023-07-12 (Crawled : 12:00) - globenewswire.com
CNTG | $0.463 0.43% 0.43% 79K
|
Commercial Services
|
| O: 1.29%
H: 7.01%
C: 4.46%
disease genetic unique
Rare Disease Diagnostics Market Research Report 2023: Expanding Patient Registry, Government Initiatives, Declining Sequencing Costs Bolsters Growth - Forecasts to 2027
Published: 2023-06-20 (Crawled : 01:00) - prnewswire.com
NVTA | $0.019 0.0% 22M
|
Health Services
|
| O: -0.4%
H: 2.02%
C: -2.02%
A | $132.73 0.22% 0.0% 1.3M
|
Health Technology
|
| O: -2.06%
H: 0.13%
C: -0.4%
ILMN | $117.43 0.63% 0.63% 1.4M
|
Health Technology
|
| O: -1.99%
H: 0.7%
C: 0.17%
CNTG | $0.463 0.43% 0.43% 79K
|
Commercial Services
|
| O: 15.28%
H: 0.0%
C: -12.33%
rare disease report research diagnostics growth market
CENTOGENE to Participate in Upcoming Conferences in February in the Lead Up to Rare Disease Day
Published: 2023-02-07 (Crawled : 12:20) - biospace.com/
CNTG | $0.463 0.43% 0.43% 79K
|
Commercial Services
|
| O: 2.96%
H: 4.31%
C: 2.88%
day rare disease
Twist Bioscience and CENTOGENE Launch Three Panels to Advance Rare Disease and Hereditary Cancer Research and Support Diagnostics
Published: 2023-01-10 (Crawled : 14:00) - biospace.com/
TWST | $27.92 -1.55% -1.58% 1.1M
|
Health Technology
|
| O: -0.28%
H: 7.69%
C: 5.78%
CNTG | $0.463 0.43% 0.43% 79K
|
Commercial Services
|
| O: 4.13%
H: 1.04%
C: 0.02%
rare research disease diagnostics bioscience cancer
CENTOGENE Launches Rare and Neurodegenerative Disease Biodata Network
Published: 2022-11-03 (Crawled : 11:00) - biospace.com/
CNTG | $0.463 0.43% 0.43% 79K
|
Commercial Services
|
| O: -0.01%
H: 2.14%
C: 2.14%
rare disease neurodegenerative
CENTOGENE and Agios Expand Partnership for Clinical Development of PYRUKYND® (mitapivat) to Treat Children With Rare Blood Disease
Published: 2022-06-13 (Crawled : 11:00) - globenewswire.com
CNTG | $0.463 0.43% 0.43% 79K
|
Commercial Services
|
| O: -4.21%
H: 4.39%
C: 3.52%
AGIO | $29.52 0.31% 0.3% 750K
|
Health Technology
|
| O: -6.12%
H: 2.7%
C: -2.36%
pyrukynd partnership blood rare disease children
CENTOGENE Contributes to Europe-Wide Efforts to Update Guidelines for Whole Genome Sequencing (WGS) in Rare Disease Diagnostics
Published: 2022-05-23 (Crawled : 11:00) - globenewswire.com
CNTG | $0.463 0.43% 0.43% 79K
|
Commercial Services
|
| O: 2.29%
H: 0.0%
C: -1.56%
guidelines rare disease diagnostics diagnostic
Global Comprehensive Metabolic Panel Testing Market to 2027 - by Disease, Test Type, Test Type, End-user and Region
Published: 2022-03-23 (Crawled : 15:00) - prnewswire.com
DGX | $128.44 2.01% 0.0% 1.6M
|
Health Services
|
| O: -0.68%
H: 0.32%
C: -0.31%
LH M | $201.48 1.02% 0.0% 770K
|
Health Services
|
| O: -0.44%
H: 0.17%
C: -1.64%
ABT | News | $107.28 1.91% 0.18% 10M
|
Health Technology
|
| O: -0.64%
H: 0.0%
C: 0.0%
OPK | $1.23 0.0% 2.7M
|
Health Technology
|
| O: -1.94%
H: 1.98%
C: -2.27%
CNTG | $0.463 0.43% 0.43% 79K
|
Commercial Services
|
| O: -0.95%
H: 4.78%
C: -1.91%
metabolic test market disease
CENTOGENE Joins Forces With Insilico Medicine for Niemann-Pick Disease Type C (NPC) Target Discovery, Applying Artificial Intelligence (AI) to Accelerate Orphan Drug Development
Published: 2022-01-20 (Crawled : 20:00) - biospace.com/
CNTG | $0.463 0.43% 0.43% 79K
|
Commercial Services
|
| O: -6.39%
H: 4.32%
C: -3.96%
artificial intelligence ema drug disease cel intel orphan drug
CENTOGENE Expands Partnership With Agios to Generate Novel Insights Into Rare Blood Diseases
Published: 2021-11-04 (Crawled : 11:00) - globenewswire.com
CNTG | $0.463 0.43% 0.43% 79K
|
Commercial Services
|
| O: 2.94%
H: 1.83%
C: -0.92%
AGIO | $29.52 0.31% 0.3% 750K
|
Health Technology
|
| O: 6.36%
H: 1.98%
C: -7.64%
disease partnership blood rare
CENTOGENE and Twist Bioscience to Develop Advanced Sequencing Tools to Make Genetic Testing Rapidly Accessible for More Patients With Rare Diseases
Published: 2021-10-06 (Crawled : 17:00) - biospace.com/
TWST | $27.92 -1.55% -1.58% 1.1M
|
Health Technology
|
| O: -0.85%
H: 1.13%
C: -1.99%
CNTG | $0.463 0.43% 0.43% 79K
|
Commercial Services
|
| O: -0.97%
H: 3.54%
C: 2.17%
disease genetic test rare
Twist Bioscience and CENTOGENE to Develop Advanced Sequencing Tools to Make Genetic Testing Rapidly Accessible for More Patients With Rare Diseases
Published: 2021-10-06 (Crawled : 13:00) - biospace.com/
TWST | $27.92 -1.55% -1.58% 1.1M
|
Health Technology
|
| O: -0.85%
H: 1.13%
C: -1.99%
CNTG | $0.463 0.43% 0.43% 79K
|
Commercial Services
|
| O: -0.97%
H: 3.54%
C: 2.17%
disease genetic test rare
CENTOGENE Appoints Patrice P. Denèfle as Chief Scientific Officer to Lead Its Data-Driven Approach to Reinvent Rare Disease Drug Discovery and Development
Published: 2021-07-27 (Crawled : 11:00) - globenewswire.com
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.54%
H: 0.65%
C: 0.49%
CNTG | $0.463 0.43% 0.43% 79K
|
Commercial Services
|
| O: -0.17%
H: 1.57%
C: 0.87%
disease drug discovery drug rare
CENTOGENE Sets Mission to Enable the Cure of 100 Rare Diseases Within the Next 10 Years Highlights strategic priorities to lead data-driven insights creation for rare diseases at its Virtual Investor Event
Published: 2021-06-22 (Crawled : 12:00) - biospace.com/
CNTG | $0.463 0.43% 0.43% 79K
|
Commercial Services
|
| O: 0.6%
H: 1.28%
C: -1.68%
disease rare
CENTOGENE Sets Mission to Enable the Cure of 100 Rare Diseases Within the Next 10 Years
Published: 2021-06-22 (Crawled : 11:00) - globenewswire.com
CNTG | $0.463 0.43% 0.43% 79K
|
Commercial Services
|
| O: 0.6%
H: 1.28%
C: -1.68%
disease set rare
CENTOGENE Reports First Quarter 2021 Financial Results in the Lead Up to Virtual Investor EventFurther signs of recovery in the core rare disease business
Published: 2021-06-16 (Crawled : 12:00) - biospace.com/
CNTG | $0.463 0.43% 0.43% 79K
|
Commercial Services
|
| O: -0.69%
H: 2.48%
C: 0.69%
disease financial results results rare
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.